Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


CARCINOEMBRYONIC ANTIGEN INCREASED side effect

What is CARCINOEMBRYONIC ANTIGEN INCREASED ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   CARCINOEMBRYONIC ANTIGEN INCREASED and Recently Reported Side Effects   CARCINOEMBRYONIC ANTIGEN INCREASED and 15 most Active Side Effect polls   CARCINOEMBRYONIC ANTIGEN INCREASED and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with CARCINOEMBRYONIC ANTIGEN INCREASED

ACCUTANE  ACTOS  BEVACIZUMAB  CAPECITABINE  CHANTIX  DILANTIN  DIOVAN  ELONTRIL  ENBREL  EPAMIN  FEMARA  FOLINIC  FORTEO  GABAPENTIN  GEMZAR  IRESSA  IRINOTECAN  LOPERAMIDE  MABTHERA  MEMANTINE  NEXIUM  OXALIPLATIN  PROPECIA  REMICADE  TARCEVA  TRACLEER  VECTIBIX  XELODA  ZOLADEX  ZOMETA  ZYVOX  


Tracleer Side Effects Report #5564776-2
Consumer or non-health professional from JAPAN reported TRACLEER problem on Nov 26, 2007. Female patient, 76 years of age, weighting 83.78 lb, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, gastric cancer stage ii, malignant pleural effusion, pericardial effusion malignant, . TRACLEER dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with OXYGEN, BERAPROST, PREDNISONE, LEVOTHYROXINE, NILVADIPINE, ALENDRONATE, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient died on 09/16/2005.

Zoladex Side Effects Report #5483583-2
ZOLADEX problem was reported by a Physician from GERMANY on Oct 08, 2007. Female patient, weighting 149.9 lb, was diagnosed with breast cancer female and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . ZOLADEX dosage: unknown. During the same period patient was treated with AROMASIN. Patient recovered.

Actos Side Effects Report #5448468-6
Consumer or non-health professional from UNITED STATES reported ACTOS problem on Aug 28, 2007. Female patient, 68 years of age, weighting 130.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . ACTOS dosage: 15 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with ULTRASE. Patient recovered.

Elontril Side Effects Report #5450168-3
ELONTRIL problem was reported by a Consumer or non-health professional from GERMANY on Sept 11, 2007. Male patient was treated with ELONTRIL. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, dry mouth, hyperhidrosis, pancreatic carcinoma, . ELONTRIL dosage: 300MG PER DAY. Patient recovered.


Tarceva Side Effects Report #5472453-1
Physician from CHINA reported TARCEVA problem on Sept 11, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with INSULIN. Patient recovered.

Tarceva Side Effects Report #5413055-2
TARCEVA problem was reported by a Consumer or non-health professional from CHINA on July 25, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with INSULIN. Patient recovered.

Irinotecan Side Effects Report #5446875-9
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Aug 16, 2006. Male patient, 47 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, metastases to liver, thrombosis, weight increased, . IRINOTECAN dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL. Patient recovered.

Zoladex Side Effects Report #5379030-1
ZOLADEX problem was reported by a Physician from GERMANY on June 27, 2007. Female patient, 48 years of age, was diagnosed with breast cancer female and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . ZOLADEX dosage: unknown. Patient recovered.

Vectibix Side Effects Report #5394471-4
Consumer or non-health professional from reported VECTIBIX problem on Mar 29, 2007. Female patient, 87 years of age, was diagnosed with colorectal cancer and was treated with VECTIBIX. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, dermatitis acneiform, pain, rash pruritic, skin haemorrhage, therapeutic response decreased, . VECTIBIX dosage: unknown. During the same period patient was treated with ATENOLOL. Patient recovered.


Remicade Side Effects Report #5396469-9
REMICADE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, 44 years of age, weighting 205.0 lb, was diagnosed with psoriatic arthropathy and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, pancreatic cyst, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5402817-3
Consumer or non-health professional from CHINA reported TARCEVA problem on July 13, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . TARCEVA dosage: unknown. Patient recovered.

Zoladex Side Effects Report #5379030-1
ZOLADEX problem was reported by a Physician from GERMANY on June 27, 2007. Female patient, 48 years of age, was diagnosed with breast cancer female and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . ZOLADEX dosage: unknown. Patient recovered.

Vectibix Side Effects Report #5394471-4
Consumer or non-health professional from reported VECTIBIX problem on Mar 29, 2007. Female patient, 87 years of age, was diagnosed with colorectal cancer and was treated with VECTIBIX. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, dermatitis acneiform, pain, rash pruritic, skin haemorrhage, therapeutic response decreased, . VECTIBIX dosage: unknown. During the same period patient was treated with ATENOLOL. Patient recovered.

Remicade Side Effects Report #5396469-9
REMICADE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, 44 years of age, weighting 205.0 lb, was diagnosed with psoriatic arthropathy and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, pancreatic cyst, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #5402817-3
Consumer or non-health professional from CHINA reported TARCEVA problem on July 13, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . TARCEVA dosage: unknown. Patient recovered.

Loperamide Side Effects Report #5773335-8
LOPERAMIDE problem was reported by a Health Professional from JAPAN on June 05, 2008. Male patient, 44 years of age, was diagnosed with diarrhoea, pyrexia and was treated with LOPERAMIDE. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . LOPERAMIDE dosage: unknown. During the same period patient was treated with LOXOPROFEN, LANSOPRAZOLE, ATORVASTATIN CALCIUM, CANDESARTAN CILEXETIL, ASPIRIN, ALLOPURINOL, NIFEDIPINE, SENNOSIDE. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5690505-8
Health Professional from UNITED STATES reported CAPECITABINE problem on May 28, 2004. Male patient, 68 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, disease progression, vomiting, . CAPECITABINE dosage: unknown. Patient died.

Dilantin Side Effects Report #5693835-9
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 25, 2008. Male patient, weighting 162.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . DILANTIN dosage: unknown. During the same period patient was treated with VITAMINS. Patient recovered.

Epamin Side Effects Report #5724364-1
Consumer or non-health professional from UNITED STATES reported EPAMIN problem on Apr 18, 2008. Male patient, weighting 162.0 lb, was diagnosed with convulsion and was treated with EPAMIN. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . EPAMIN dosage: unknown. During the same period patient was treated with VITAMINS. Patient recovered.


Chantix Side Effects Report #5322879-1
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Male patient, weighting 220.5 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . CHANTIX dosage: unknown. During the same period patient was treated with CELEXA, KLONOPIN, COREG, CHOLESTEROL. Patient recovered.

Vectibix Side Effects Report #5307171-3
Consumer or non-health professional from UNITED STATES reported VECTIBIX problem on Feb 22, 2007. Female patient, weighting 190.3 lb, was diagnosed with colorectal cancer and was treated with VECTIBIX. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, dermatitis acneiform, dry skin, . VECTIBIX dosage: unknown. During the same period patient was treated with ATIVAN, BENADRYL, ZOLOFT, ALLEGRA, ADVAIR DISKUS, NASACORT. Patient recovered.

Bevacizumab Side Effects Report #5309051-6
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Apr 17, 2007. Female patient, weighting 93.98 lb, was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, haemoglobin increased, hyponatraemia, pancreatitis, . BEVACIZUMAB dosage: 5 MG/KG, 2/MONTH. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5261054-6
Physician from JAPAN reported GEMZAR problem on Feb 26, 2007. Female patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, disseminated intravascular coagulation, jaundice cholestatic, malignant neoplasm progression, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died on 01/01/2005.

Iressa Side Effects Report #5265371-5
IRESSA problem was reported by a Physician from UNITED STATES on Jan 20, 2004. Female patient, 54 years of age, weighting 132.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, . IRESSA dosage: 250 MG PO. During the same period patient was treated with AREDIA. Patient recovered.

Diovan Side Effects Report #5669521-8
Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Mar 11, 2008. Female patient, 65 years of age, weighting 130.0 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: biopsy liver, carcinoembryonic antigen increased, catheterisation venous, colonoscopy, constipation, deep vein thrombosis, haemoglobin decreased, hepatic neoplasm malignant, hypertension, . DIOVAN dosage: 160 MG, UNK. During the same period patient was treated with LISINOPRIL. Patient was hospitalized. Patient recovered.

Xeloda Side Effects Report #5674227-5
XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient, 72 years of age, was diagnosed with colorectal cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: anorexia, carcinoembryonic antigen increased, palmar-plantar erythrodysaesthesia syndrome, weight decreased, . XELODA dosage: unknown. Patient recovered.

Propecia Side Effects Report #5689578-8
Physician from JAPAN reported PROPECIA problem on Mar 21, 2008. Male patient, 33 years of age, was diagnosed with androgenetic alopecia and was treated with PROPECIA. After drug was administered, patient experienced the following problems/side effects: blood uric acid increased, carcinoembryonic antigen increased, . PROPECIA dosage: unknown. Patient recovered.

Forteo Side Effects Report #5636455-4
FORTEO problem was reported by a Physician from SPAIN on Feb 11, 2008. Female patient, 60 years of age, was diagnosed with osteoporotic fracture and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, carcinoembryonic antigen increased, echinococciasis, weight decreased, . FORTEO dosage: unknown. Patient recovered.

Xeloda Side Effects Report #5476844-4
Consumer or non-health professional from UNITED STATES reported XELODA problem on Sept 24, 2007. Male patient, 76 years of age, weighting 250.0 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: breast tenderness, carcinoembryonic antigen increased, . XELODA dosage: PATIENT TOOK 1300 MG (TWO 500 MG TABLETS AND TWO 150 MG TABLETS) TWICE PER DAY (MORNING AND EVENING+. Patient recovered.

Zometa Side Effects Report #5448233-X
ZOMETA problem was reported by a Physician from JAPAN on Sept 03, 2007. Female patient, 63 years of age, weighting 138.9 lb, was diagnosed with metastases to bone, lung neoplasm malignant, nausea, oesophagitis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, carcinoembryonic antigen increased, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypersensitivity, neutrophil count decreased, pruritus, pyrexia, . ZOMETA dosage: 4 MG, ONCE/SINGLE. During the same period patient was treated with PARAPLATIN, PACLITAXEL, PRIMPERAN, FAMOTIDINE, ALUMINIUM HYDROXIDE W, ALLOID. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5476517-8
Physician from UNITED STATES reported FEMARA problem on Apr 09, 2007. Female patient, 40 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 15-3 increased, carcinoembryonic antigen increased, constipation, dizziness, hot flush, hypertension, lymphocyte count decreased, myalgia, pain, . FEMARA dosage: 2.5 MG, QD, ORAL. During the same period patient was treated with CLONIDINE, EFFEXOR. Patient recovered.

Enbrel Side Effects Report #5422237-5
ENBREL problem was reported by a Consumer or non-health professional from SPAIN on Aug 13, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 125 increased, carcinoembryonic antigen increased, tumour marker increased, . ENBREL dosage: unknown. Patient recovered.

Zometa Side Effects Report #5430330-6
Physician from JAPAN reported ZOMETA problem on Aug 22, 2007. Female patient, 63 years of age, weighting 138.9 lb, was diagnosed with metastases to bone, lung neoplasm malignant, nausea, oesophagitis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, carcinoembryonic antigen increased, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypersensitivity, neutrophil count decreased, pruritus, pyrexia, . ZOMETA dosage: 4 MG, ONCE/SINGLE. During the same period patient was treated with PARAPLATIN, PACLITAXEL, PRIMPERAN, FAMOTIDINE, ALUMINIUM HYDROXIDE W, ALLOID. Patient was hospitalized. Patient recovered.

Zyvox Side Effects Report #5387554-6
ZYVOX problem was reported by a Pharmacist from UNITED STATES on July 11, 2007. Female patient, 91 years of age, was diagnosed with pneumonia staphylococcal and was treated with ZYVOX. After drug was administered, patient experienced the following problems/side effects: anaemia, carcinoembryonic antigen increased, diverticulitis, fungaemia, fungal infection, gastritis, pancytopenia, . ZYVOX dosage: 600 MG BID IV. Patient was hospitalized. Patient recovered.

Oxaliplatin Side Effects Report #5390866-3
Consumer or non-health professional from ITALY reported OXALIPLATIN problem on July 02, 2007. Female patient, 76 years of age, was diagnosed with rectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, carcinoembryonic antigen increased, disease progression, metastases to lung, metastases to salivary gland, metastases to skin, mucosal inflammation, rectal cancer metastatic, treatment noncompliance, . OXALIPLATIN dosage: 100 MG/M2, ON DAY 1, REPEATED EVERY 14 DAYS,. During the same period patient was treated with FLUOROURACIL, RALTITREXED. Patient died on 05/01/2006.

Folinic Side Effects Report #5394895-5
FOLINIC ACID problem was reported by a Physician from ITALY on July 10, 2007. Female patient, 76 years of age, was diagnosed with rectal cancer and was treated with FOLINIC ACID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, carcinoembryonic antigen increased, disease progression, metastasis, metastatic salivary gland cancer, mucosal inflammation, necrosis, skin cancer metastatic, skin nodule, . FOLINIC ACID dosage: 250 MG/M2 PER_CYCLE. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, RALTITREXED, CAPECITABINE, IRINOTECAN. Patient recovered.

Zyvox Side Effects Report #5387554-6
Pharmacist from UNITED STATES reported ZYVOX problem on July 11, 2007. Female patient, 91 years of age, was diagnosed with pneumonia staphylococcal and was treated with ZYVOX. After drug was administered, patient experienced the following problems/side effects: anaemia, carcinoembryonic antigen increased, diverticulitis, fungaemia, fungal infection, gastritis, pancytopenia, . ZYVOX dosage: 600 MG BID IV. Patient was hospitalized. Patient recovered.

Oxaliplatin Side Effects Report #5390866-3
OXALIPLATIN problem was reported by a Consumer or non-health professional from ITALY on July 02, 2007. Female patient, 76 years of age, was diagnosed with rectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, carcinoembryonic antigen increased, disease progression, metastases to lung, metastases to salivary gland, metastases to skin, mucosal inflammation, rectal cancer metastatic, treatment noncompliance, . OXALIPLATIN dosage: 100 MG/M2, ON DAY 1, REPEATED EVERY 14 DAYS,. During the same period patient was treated with FLUOROURACIL, RALTITREXED. Patient died on 05/01/2006.

Folinic Side Effects Report #5394895-5
Physician from ITALY reported FOLINIC ACID problem on July 10, 2007. Female patient, 76 years of age, was diagnosed with rectal cancer and was treated with FOLINIC ACID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, carcinoembryonic antigen increased, disease progression, metastasis, metastatic salivary gland cancer, mucosal inflammation, necrosis, skin cancer metastatic, skin nodule, . FOLINIC ACID dosage: 250 MG/M2 PER_CYCLE. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, RALTITREXED, CAPECITABINE, IRINOTECAN. Patient recovered.

Propecia Side Effects Report #5759932-4
PROPECIA problem was reported by a Physician from JAPAN on May 29, 2008. Male patient, 33 years of age, was diagnosed with androgenetic alopecia and was treated with PROPECIA. After drug was administered, patient experienced the following problems/side effects: blood uric acid increased, carcinoembryonic antigen increased, . PROPECIA dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5786587-5
Physician from UNITED KINGDOM reported MABTHERA problem on June 10, 2008. Female patient was diagnosed with idiopathic thrombocytopenic purpura and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: anaemia, carcinoembryonic antigen increased, large intestine perforation, . MABTHERA dosage: 800 MG, UNK. Patient was hospitalized. Patient recovered.

Xeloda Side Effects Report #5696153-8
XELODA problem was reported by a Consumer or non-health professional from CHINA on Mar 25, 2008. Female patient, 44 years of age, weighting 110.2 lb, was diagnosed with gastric cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, carcinoembryonic antigen increased, . XELODA dosage: unknown. Patient recovered.

Gabapentin Side Effects Report #5360988-1
Consumer or non-health professional from TURKEY reported GABAPENTIN problem on June 06, 2007. Female patient, 35 years of age, was diagnosed with pain in extremity, neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: breast mass, carcinoembryonic antigen increased, . GABAPENTIN dosage: unknown. During the same period patient was treated with PREGABALIN, TRAMADOL, DIAZEPAM, DICLOFENAC. Patient recovered.

Nexium Side Effects Report #5312596-6
NEXIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2007. Female patient, 53 years of age, weighting 149.9 lb, was diagnosed with gastric disorder and was treated with NEXIUM. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 27.29 increased, carcinoembryonic antigen increased, liver function test, . NEXIUM dosage: unknown. During the same period patient was treated with SYNTHROID, ASCORBIC ACID, PLE SUPPLEMENTS, ANTIOXIDANTS, CHINESE HERBS, ELAVIL, AVASTIN. Patient recovered.

Iressa Side Effects Report #5265257-6
Physician from UNITED STATES reported IRESSA problem on Jan 27, 2004. Female patient, 61 years of age, weighting 122.0 lb, was diagnosed with non-small cell lung cancer and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 27.29 increased, carcinoembryonic antigen increased, pain, weight increased, . IRESSA dosage: 250 MG PO. During the same period patient was treated with VITAMIN CAP, XANAX, ASCORBIC ACID, VITAMIN E, BIOTIN. Patient recovered.

Iressa Side Effects Report #5268908-5
IRESSA problem was reported by a Physician from UNITED STATES on Jan 27, 2004. Female patient, 61 years of age, weighting 122.0 lb, was diagnosed with non-small cell lung cancer and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 27.29 increased, carcinoembryonic antigen increased, pain, weight increased, . IRESSA dosage: 250 MG PO. During the same period patient was treated with VITAMIN CAP, XANAX, ASCORBIC ACID, VITAMIN E, BIOTIN. Patient recovered.

Memantine Side Effects Report #5550303-2
Health Professional from GERMANY reported MEMANTINE problem on Nov 26, 2007. Female patient, 78 years of age, weighting 138.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: breast cancer female, carbohydrate antigen 15-3 increased, carcinoembryonic antigen increased, lipoma, oestrogen receptor assay positive, pain, progesterone receptor assay positive, . MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE, ATORVASTATIN CALCIUM, FUROSEMIDE, THEOPHYLLINE. Patient recovered.

Accutane Side Effects Report #5576181-3
ACCUTANE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 24, 2007. Male patient, 21 years of age, weighting 147.0 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood bilirubin increased, carcinoembryonic antigen increased, colitis, colitis ulcerative, crohn's disease, dry skin, emotional distress, gastrointestinal disorder, . ACCUTANE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Oxaliplatin Side Effects Report #5698368-1
Consumer or non-health professional from ITALY reported OXALIPLATIN problem on Mar 25, 2008. Female patient, 76 years of age, was diagnosed with rectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, biopsy salivary gland abnormal, carcinoembryonic antigen increased, gastrointestinal neoplasm, malignant neoplasm progression, metastases to lung, metastatic neoplasm, mucosal inflammation, . OXALIPLATIN dosage: 100 MG/M2 STOPPED (ON DAY 1 FOR 2 14-DAYS-CYCLES). During the same period patient was treated with FOLINIC ACID, FLUOROURACIL, RALTITREXID. Patient was hospitalized. Patient died.

Femara Side Effects Report #5341449-2
FEMARA problem was reported by a Pharmacist from GERMANY on May 22, 2007. Female patient, 52 years of age, was diagnosed with breast cancer recurrent and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: back pain, bone density decreased, carcinoembryonic antigen increased, lymphadenopathy, metastases to lymph nodes, osteopenia, ultrasound thyroid abnormal, . FEMARA dosage: 2.5 MG, QD. During the same period patient was treated with ZOLADEX. Patient recovered.

Accutane Side Effects Report #5304409-3
Consumer or non-health professional from UNITED STATES reported ACCUTANE problem on Apr 11, 2007. Male patient, 21 years of age, weighting 147.0 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood bilirubin increased, carcinoembryonic antigen increased, colitis, colitis ulcerative, crohn's disease, dry skin, emotional distress, gastrointestinal disorder, . ACCUTANE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about CARCINOEMBRYONIC ANTIGEN INCREASED side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about CARCINOEMBRYONIC ANTIGEN INCREASED